| Model Number |
PED2-400-14 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Bruise/Contusion (1754); Headache (1880); Vasoconstriction (2126); Ischemia Stroke (4418)
|
| Date of Event |
08/26/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that a patient treated with a ped2 pipeline, navien58 catheter, and phenom27 catheter right internal carotid artery ascending cervical segment vasospasm. intraarterial verapamil 10 mg was administered.No hospitalization.The event resolved on (b)(6) 2024.The event had a causal relationship with the procedure. on (b)(6) 2024 office visit: continuation of bruising plavix is causing.Baseline aneurysm characteristics: side (hemisphere): right.Segment of internal carotid artery (ica): c6.Location of aneurysm in vessel: sidewall.Aneurysm morphology: saccular.Maximum aneurysm diameter: 4mm.Aneurysm dome height: 4mm.Aneurysm dome width: 4mm.Aneurysm neck size: 4mm.Parent artery diameter distal to aneurysm: 3mm.Parent artery diameter proximal to aneurysm: 3mm.Additional information received reported intra-arterial verapamil 10mg was administered during the procedure to address the vasospasm.Site assessment determined the vasospasm had a causal relationship to the procedure.Navien and phenom catheter identifying information was not available.2025-feb-22 lsh 1308220934 (hcp, sdy): additional information received reported post procedure mri (b)(6) 2025 indicates multiple punctate recent infarcts within the right cerebral hemisphere, likely related to angiography.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information received reported that the sponsor assessed the vasospasm as caused by the procedure.It was reported that the patient experienced headache and bruising on 26-sep-2024.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information received reported excess bruising after using plavix.Investigator assessed the event as related to plavix.No change in medication was made.
|
| |
|
Search Alerts/Recalls
|